Antidepressant Effect Seen for Anti-Inflammatory Meds

This article originally appeared here.
Share this content:
Antidepressant Effect Seen for Anti-Inflammatory Meds
Antidepressant Effect Seen for Anti-Inflammatory Meds

(HealthDay News) -- Anti-inflammatory agents may decrease depression and depressive symptoms, according to research published in the December issue of JAMA Psychiatry.

Ole Köhler, M.D., of Aarhus University Hospital in Risskov, Denmark, and colleagues conducted a systematic review of the literature and performed a meta-analysis of data from 14 randomized clinical trials. The authors sought to assess the antidepressant effects of anti-inflammatory agents and possible adverse effects associated with such interventions. Ten trials evaluated the use of nonsteroidal anti-inflammatory agents (NSAIDs), and four trials evaluated the use of cytokine inhibitors.

The researchers found that the pooled effect estimate suggested that, compared with placebo, anti-inflammatory agents decreased depressive symptoms in studies of patients with depression or depressive symptoms. Differences in the inclusion of clinical depression versus depressive symptoms, or the use of NSAIDs versus cytokine inhibitors, did not explain the heterogeneity of the studies. In six studies, use of anti-inflammatory treatment, compared with placebo, did not appear to increase the number of gastrointestinal or cardiovascular adverse effects after six weeks, or the number of infections after 12 weeks.

"This study supports a proof-of-concept concerning the use of anti-inflammatory treatment in depression," the authors write. "Identification of subgroups that could benefit from such treatment might be warranted."

Pfizer conducted five of the studies included in the meta-analysis.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »